GPAT4 Polyclonal Antibody, HRP Conjugated
Product Specifications
Background
Lysophosphatidic acid acyltransferases (EC 2.3.1.51) catalyze the conversion of lysophosphatidic acid (LPA) to phosphatidic acid (PA) . LPA and PA are involved in signal transduction and lipid biosynthesis.[supplied by OMIM, Apr 2004].
Synonyms
1 acyl sn glycerol 3 phosphate acyltransferase zeta; 1 AGP acyltransferase 6; 1 AGPAT 6; 1-acylglycerol-3-phosphate O-acyltransferase 6; 1-AGP acyltransferase 6; 1-AGPAT 6; Acyl-CoA:glycerol-3-phosphate acyltransferase 4; AGPAT6; Glycerol-3-phosphate acyltransferase 4; GPAT4; GPAT4_HUMAN; LPAAT zeta; LPAAT-zeta; Lysophosphatidic acid acyltransferase zeta.
Cellular Locus
Cytoplasm
Host
Rabbit
Cross Reactivity
Human, Mouse
Immunogen
251-350/648
Target
GPAT4
Clonality
Polyclonal
Isotype
IgG
Conjugation
HRP
Source
KLH conjugated synthetic peptide derived from human GPAT4
Applications
WB, ELISA, IHC-P, IHC-F
Purification
Purified by Protein A.
Concentration
1µg/µl
Dilution
WB (1:300-5000), ELISA (1:500-1000), IHC-P (1:200-400), IHC-F (1:100-500)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Predicted Cross Reactivity
Rat, Cow, Sheep, Pig, Horse, Chicken, Rabbit
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
